Monthly Prescribing Reference (registration)FDA approves Novo Nordisk's long-awaited diabetes drugReutersThe U.S. Food and Drug Administration on Friday approved Danish drugmaker Novo Nordisk's diabetes drug Tresiba, two years after rejecting the long-acting form of insulin. The regulator also approved the company's Ryzodeg, an injection that combines ...FDA Approves Tresiba, Ryzodeg for DiabetesEndocrinology AdvisorNovo Nordisk receives US FDA approval for Tresiba(R) and Ryzodeg(R) 70/30MarketWatchFDA approves two new drug treatments for diabetes mellitusFDA.govMonthly Prescribing Reference (registration) -FierceBiotech -Seeking Alphaall 31 news articles »
FDA approves Novo Nordisk's long
Rating: 4.5
Diposkan Oleh: Unknown
